Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic

Title
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 118, Issue 11, Pages 3651-3659
Publisher
American Society for Clinical Investigation
Online
2008-10-22
DOI
10.1172/jci35437

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started